Abstract: The carotid artery plaque properties are quantitatively determined by a carotid artery echo whereby predicting incidence of cerebral infarction or myocardial infarct. A method includes obtaining, coloring, and displaying steps. In the obtaining step, the integrated amounts per unit time of echo signals corresponding to pixels of an echo image of carotid artery plaque are obtained. The signals are obtained when the image is obtained by an IBS method. In the coloring step, the relationship between ranges and colors is referenced. The available full range of the integrated amount is previously divided into the ranges. The colors are assigned to the ranges. The pixels are classified into the ranges in accordance with the integrated amounts corresponding to the pixels. The pixels of the image are colored in colors corresponding to the ranges of the pixels. In the displaying step, the colored echo image is displayed on a display portion 30.

Abstract: The carotid artery plaque properties are quantitatively determined by a carotid artery echo whereby predicting incidence of cerebral infarction or myocardial infarct. A method includes obtaining, coloring, and displaying steps. In the obtaining step, the integrated amounts per unit time of echo signals corresponding to pixels of an echo image of carotid artery plaque are obtained. The signals are obtained when the image is obtained by an IBS method. In the coloring step, the relationship between ranges and colors is referenced. The available full range of the integrated amount is previously divided into the ranges. The colors are assigned to the ranges. The pixels are classified into the ranges in accordance with the integrated amounts corresponding to the pixels. The pixels of the image are colored in colors corresponding to the ranges of the pixels. In the displaying step, the colored echo image is displayed on a display portion 30.

Abstract: A preventive and/or therapeutic agent for post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening, wherein the agent contains, as an active ingredient, a monocyte chemoattractant protein-1 (MCP-1) function inhibitor. Administration of the MCP-1 function inhibitor enables prevention and treatment of post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening.

Abstract: A preventive and/or therapeutic agent for post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening, wherein the agent contains, as an active ingredient, a monocyte chemoattractant protein-1 (MCP-1) function inhibitor. Administration of the MCP-1 function inhibitor enables prevention and treatment of post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening.

Abstract: This application is to provide a medical guide wire serving also as a catheter which requires only single insertion operation, and nevertheless by which it is possible to apply a pressure to a specified part on the internal wall of a vessel, to thereby expand the narrowed lumen, or to cut the part for removal, as well as to apply a therapeutic agent to the part.